QurAlis
Taylor Gray has extensive experience in the biotechnology field, currently serving as a Senior Program Manager at QurAlis since July 2019, with prior roles including Program Manager, Scientist I, and Senior Associate Scientist. Before joining QurAlis, Taylor was an Associate Scientist II in Biogen's In-Vitro Technologies group, focusing on developing blood-brain barrier models for drug discovery related to neurological diseases. Prior experience includes a contract position with Biogen as an Associate Scientist I through Integrated Resources, Inc., and a Graduate Research Assistant role at the University of Massachusetts Amherst, where Taylor investigated the link between adenovirus infections and breast cancer risk. Taylor holds a Master of Science in Microbiology and a Bachelor of Science in Microbiology, both from the University of Massachusetts Amherst.
This person is not in any teams
QurAlis
1 followers
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.